TMO Valuation Metrics
TMO Stock Price Metrics
TMO Dividend Metrics
TMO Growth Rate Metrics
TMO Discounted Cash Flow Metrics
| Fair Value Price | $537.66 |
| Margin of Safety | 8.82% |
TMO Revenue Metrics
TMO PE Ratio Metrics
| PE Ratio | 27.16 |
| PE Ratio Avg TTM | 29.19 |
| PE Ratio Avg 3Y | 32.54 |
| Current VS TTM Avg | -6.96% |
| Current VS 3Y Avg | -16.55% |
| Current VS 5Y Avg | -12.89% |
TMO PS Ratio Metrics
| PS Ratio | 4.08 |
| PS Ratio Avg TTM | 4.39 |
| PS Ratio Avg 3Y | 4.67 |
| Current VS TTM Avg | -6.99% |
| Current VS 3Y Avg | -12.58% |
| Current VS 5Y Avg | -17.95% |
TMO PB Ratio Metrics
| PB Ratio | 3.55 |
| PB Ratio Avg TTM | 3.75 |
| PB Ratio Avg 3Y | 4.22 |
| Current VS TTM Avg | -5.39% |
| Current VS 3Y Avg | -15.81% |
| Current VS 5Y Avg | -24.93% |
TMO Price to Free Cash Flow Ratio Metrics
| PFCF Ratio | 27.31 |
| PFCF Ratio Avg TTM | 30.55 |
| PFCF Ratio Avg 3Y | 30.03 |
| Current VS TTM Avg | -10.59% |
| Current VS 3Y Avg | -9.06% |
| Current VS 5Y Avg | -10.89% |
TMO Debt to Equity Ratio Metrics
| Debt/Equity Ratio | 0.76 |
| Debt/Equity Ratio Avg TTM | 0.71 |
| Debt/Equity Ratio Avg 3Y | 0.76 |
| Current VS TTM Avg | +7.04% |
| Current VS 3Y Avg | +0.66% |
| Current VS 5Y Avg | +0.00% |
TMO PEG Ratio Metrics
| PEG Ratio | 4.51 |
| PEG Ratio Avg TTM | 4.51 |
| PEG Ratio Avg 3Y | 4.51 |
| Current VS TTM Avg | 0.00% |
| Current VS 3Y Avg | 0.00% |
| Current VS 5Y Avg | 0.00% |
TMO FCF Yield
| FCF Yield | 3.66% |
| FCF Yield Avg TTM | 3.35% |
| FCF Yield Avg 3Y | 3.39% |
| Current VS TTM Avg | +9.32% |
| Current VS 3Y Avg | +7.89% |
| Current VS 5Y Avg | +10.23% |
TMO Earnings Yield
| Earnings Yield | 3.68% |
| Earnings Yield Avg TTM | 3.48% |
| Earnings Yield Avg 3Y | 3.13% |
| Current VS TTM Avg | +5.90% |
| Current VS 3Y Avg | +17.42% |
| Current VS 5Y Avg | +12.76% |
TMO EV/EBIT Ratio Metrics
| Ev/Ebit Ratio | 27.94 |
| Ev/Ebit Ratio Avg TTM | 28.25 |
| Ev/Ebit Ratio Avg 3Y | 30.56 |
| Current VS TTM Avg | -1.10% |
| Current VS 3Y Avg | -8.58% |
| Current VS 5Y Avg | -1.28% |
TMO EV/EBITDA Ratio Metrics
| Ev/Ebitda Ratio | 20.09 |
| Ev/Ebitda Ratio Avg TTM | 19.72 |
| Ev/Ebitda Ratio Avg 3Y | 20.47 |
| Current VS TTM Avg | +1.87% |
| Current VS 3Y Avg | -1.86% |
| Current VS 5Y Avg | -1.10% |
TMO EV/Assets Ratio Metrics
| Ev/Assets Ratio | 1.98 |
| Ev/Assets Ratio Avg TTM | 2.16 |
| Ev/Assets Ratio Avg 3Y | 2.33 |
| Current VS TTM Avg | -8.13% |
| Current VS 3Y Avg | -15.11% |
| Current VS 5Y Avg | -23.03% |
TMO EV/Sales Ratio Metrics
| Ev/Sales Ratio | 4.96 |
| Ev/Sales Ratio Avg TTM | 5.13 |
| Ev/Sales Ratio Avg 3Y | 5.38 |
| Current VS TTM Avg | -3.30% |
| Current VS 3Y Avg | -7.74% |
| Current VS 5Y Avg | -11.67% |
TMO Current Ratio Metrics
| Current Ratio | 1.89 |
| Current Ratio Avg TTM | 1.77 |
| Current Ratio Avg 3Y | 1.69 |
| Current VS TTM Avg | +6.48% |
| Current VS 3Y Avg | +11.50% |
| Current VS 5Y Avg | +8.93% |
TMO Quick Ratio Metrics
| Quick Ratio | 1.53 |
| Quick Ratio Avg TTM | 1.41 |
| Quick Ratio Avg 3Y | 1.34 |
| Current VS TTM Avg | +8.51% |
| Current VS 3Y Avg | +14.18% |
| Current VS 5Y Avg | +11.68% |
TMO ROIC Metrics
| ROIC | 7.58% |
| ROIC Avg 3Y | 8.16% |
| ROIC Avg 5Y | 9.10% |
| Current VS 3Y Avg | -7.08% |
| Current VS 5Y Avg | -16.75% |
| Current VS 10Y Avg | -4.97% |
TMO Return on Assets Metrics
| ROA | 6.11 |
| ROA Avg TTM | 6.31 |
| ROA Avg 3Y | 6.46 |
| Current VS TTM Avg | -3.17% |
| Current VS 3Y Avg | -5.42% |
| Current VS 5Y Avg | -15.12% |
TMO Return on Equity Metrics
| ROE | 12.61 |
| ROE Avg TTM | 12.70 |
| ROE Avg 3Y | 13.51 |
| Current VS TTM Avg | -0.67% |
| Current VS 3Y Avg | -6.63% |
| Current VS 5Y Avg | -17.25% |
TMO Net Profit Margin Metrics
| Net Profit Margin | 15.12% |
| Net Profit Margin Avg TTM | 14.95% |
| Net Profit Margin Avg 3Y | 14.84% |
| Current VS TTM Avg | +1.17% |
| Current VS 3Y Avg | +1.90% |
| Current VS 5Y Avg | -8.22% |
Last Updated: Tuesday, June 9, 2026
About Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. is a global leader in scientific services, providing a comprehensive range of offerings that include life sciences solutions, advanced analytical instruments, specialized diagnostic products, and an extensive portfolio of laboratory supplies and biopharmaceutical services. The company's reach extends across North America, Europe, Asia-Pacific, and other international markets. Its Life Sciences Solutions division furnishes researchers with essential reagents, state-of-the-art instruments, and consumables vital for biological and medical exploration, the development and manufacturing of therapeutics and vaccines, and the detection of infections and various diseases. This segment encompasses bioscience, genetic science, and bioproduction technologies, serving a broad spectrum of clients in the pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and governmental sectors. The Analytical Instruments segment delivers a variety of precision instruments, consumables, software, and support services to pharmaceutical, biotechnology, academic, governmental, environmental, and industrial research environments, as well as clinical laboratories. The Specialty Diagnostics segment offers an array of diagnostic tools, including liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, alongside calibrators, controls, protein detection assays, and accompanying instruments. This also features the creation and distribution of complete blood test systems to aid in the clinical diagnosis and monitoring of allergies, asthma, and autoimmune diseases. Furthermore, it provides dehydrated and prepared culture media, specimen collection and transport systems, related instrumentation and consumables, human leukocyte antigen (HLA) typing and testing crucial for the organ transplant sector, and other healthcare products. Lastly, the Laboratory Products and Biopharma Services segment supplies laboratory equipment, serves the research and safety markets through its channels, and offers extensive pharmaceutical services, encompassing clinical research support. The company's products and services are distributed through a dedicated direct sales team, customer service professionals, online commerce platforms, and a network of third-party distributors. Its recognized brands include Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. Thermo Fisher Scientific Inc. was established in 1956 and is headquartered in Waltham, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Marc N. Casper